Chronic Myeloproliferative Disorders Terminated Phase Trials for Morphine (DB00295)

IndicationStatusPhase
DBCOND0028462 (Chronic Myeloproliferative Disorders)TerminatedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00726830Methadone, Morphine, or Oxycodone in Treating Pain in Patients With CancerSupportive Care